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One titrimetric and two spectrophotometricmethodswhich are simple, sensitive, and economic are described for the determination
of sumatriptan succinate (STS) in bulk drug and in tablet dosage form using N-bromosuccinimide (NBS) as a brominating agent.
In titrimetry, aqueous solution of STS is treated with a measured excess of NBS in acetic acid medium, and after the bromination
of STS is judged to be complete, the unreacted NBS is determined iodometrically (method A). Spectrophotometric methods entail
addition of a known excess of NBS in acid medium followed by the determination of residual NBS by its reaction with excess
iodide, and the liberated iodine (I
3
−) is either measured at 370 nm (method B) or liberated iodine is reacted with starch followed
by the measurement of the blue colored starch-iodine complex at 570 nm (method C). Titrimetric method is applicable over range
1.0–10.0mg STS (method A), and the reaction stoichiometry is found to be 1 : 3 (STS : NBS).The spectrophotometric methods obey
Beer’s law for concentration range 0.6–15.0𝜇gmL−1 (method B) and 0.2–4.0 𝜇gmL−1 (method C). The calculated apparent molar
absorptivity values were found to be 2.10 × 104 and 7.44 × 104 Lmol−1 cm−1, for method B and method C, respectively.
1. Introduction
Triptans are a group of tryptamine-based drugs used in the
acute treatment of migraine headaches. Sumatriptan succi-
nate (Figure 1) is one among them and is structurally related
to the neurotransmitter serotonin. Sumatriptan succinate
(STS) is a 5-hydroxytryptamine (5-HT) receptor subtype
(a member of the 5-HT 1D family) having only a week affinity
for 5-HT
1A, 5-HT5A, and 5-HT7 receptors and chemically
designated as [3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-
N-methylmethanesulphonamide hydrogen butanedioate [1].
STS acts by selectively binding to serotonin type-1D receptors
(serotonin agonist) and rapidly terminates a migraine attack
while eliminating associated symptoms such as nausea, vom-
iting, and light and sound sensitivity [2].
STS has officialmonographs in BP [1], EP [3], andUSP [4]
which describe liquid chromatographicmethods for the assay
of STS. From the literature survey, it is found that high per-
formance liquid chromatography (HPLC) has been used for
the assay of STS in human plasma [5, 6], human serum
[7], rabbit plasma [8], and human plasma and urine [9]
whereas liquid chromatography-mass spectrophotometry is
used (LC-MS/MS) in body fluids [10] and human plasma [11].
Several methods have been reported for the determination of
STS in pharmaceuticals and include UV-spectrophotometry
[12–16], HPLC [17–20], ultra performance liquid chromatog-
raphy (UPLC) [21], high performance thin layer chromatog-
raphy (HPTLC) [16, 22], capillary electrophoresis [23], micel-
lar electrokinetic chromatography [24], and voltammetry
[25–27].
Besides, STS in pharmaceuticals is reported to have
been determined by visible spectrophotometry employing
different reaction schemes. Two methods were reported by
Kalyanaramu and Raghubabu [28]; first method was based
on oxidative coupling of STS with brucine in presence of
sodium metaperiodate, and the second method was based
on the formation of internal salt between drug and aconitic
anhydride, dehydration product of citric acid with acetic
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Figure 1: Structure of STS.
anhydride. The same authors reported a method based on
the formation of inner molecular complex between drug and
sodium nitroprusside in acetaldehyde [29]. A green colored
ternary complex formed by the drug with cobalt-thiocyanate
was extracted into benzene and measured at 630 nm and
served as the basis of its assay [30]. Tropaeolin 000 is reported
to form chloroform extractable orange-colored ion-pair with
STS having an absorption maximum at 483 nm, and this was
used for the sensitive assay of the drug by Kalyanaramu and
Raghubabu [31].
Kalyanaramu et al. [32] reported two methods based on
charge transfer reaction. The first method is based on the
formation of charge transfer complex between the drug and
chloranil, while the second method is based on the interac-
tion of N-alkyl vinyl amine formed from the condensation of
the free secondary amine group in the drug and acetaldehyde
with p-chloranil to give vinyl amino substituted quinone.
Fathima et al. [33] reported a method based on C-T com-
plexation reaction of drug with p-chloranilic acid. The reac-
tion between STS and sodium salt of 1,2-naphthaquinone-
4-sulphonic acid (Folin reagent) yielded a brown colored
chromogen [34] forming the basis for the assay of the
drug. Based on a well-known redox reaction and employing
Folin-Ciocalteu’s reagent [35], the drug in pharmaceutical
dosage forms was determined by Tipre and Vivia. Satya-
narayana and Rao [36] have described two methods using
the reaction between drug and in situ bromine and the unre-
acted bromine measured either by methyl orange or indigo
carmine.
No titrimetric method was found in the literature for
the quantification of STS in pharmaceuticals. The reported
visible spectrophotometric methods suffer from one or more
disadvantages such as rigid pH control, heating and/or
extraction step, use of multistep reaction/s, longer contact
time, less stable colored species, and narrow linear dynamic
range as indicated in Table 1.
The present paper describes one titrimetric and two
visible spectrophotometric methods based on the bromi-
nation reaction by NBS. Simplicity, sensitivity, wide linear
ranges, mild experimental conditions, and above all cost-
effectiveness characterize the proposed methods. Optimum
conditions were established and all the methods were val-
idated according to ICH guidelines. The validated meth-
ods when applied to the determination of STS in tablets
yielded results which were in good agreement with the label
claim.
2. Experiment
2.1. Apparatus. A Systronics model 106 digital spectropho-
tometer with 1 cm path length matched quartz cells was used
to record the absorbance values.
2.2. Reagents and Standards. All chemicals used were of
analytical reagent grade. Distilled water was used throughout
the investigation.
N-Bromosuccinimide (0.01M, 200 𝜇gmL−1 and 60 𝜇gmL−1).
An approximately 0.01M solution was prepared by dissolving
about 1.8 g of NBS (SRL Research Chemicals, Mumbai, India)
in water with the aid of heat and diluted to one liter water.
The solution was standardized iodometrically [37] and kept
in an amber colored bottle and stored in a refrigerator
and used in titrimetry. It was diluted appropriately to get
working concentrations of 200 and 60𝜇gmL−1 NBS for use
in spectrophotometric method B andmethod C, respectively.
Potassium Iodide. A 5% potassium iodide (Merck, Mumbai,
India) solution was prepared by dissolving 5 g potassium
iodide with water in a 100mL calibrated flask. This solution
was prepared afresh daily. A 2% solution was prepared
separately for spectrophotometric work.
Starch Solution. One gram of starch (LOBA Chemie Ltd.,
Mumbai, India) was made into paste with water and slowly
poured with constant stirring into 100mL boiling water,
boiled for 5min, cooled, and used.This solutionwas prepared
freshly every day.
Hydrochloric Acid. Concentrated hydrochloric acid (Merck,
Mumbai, India, Sp. gr. 1.18) was diluted appropriately with
water to get 2M HCl for use in all the methods.
Sodium Acetate. A 3M aqueous solution of sodium acetate
was prepared by dissolving suitable quantity of sodium
acetate trihydrate crystals (Merck, Mumbai, India) in water
for use in spectrophotometric method B.
Standard Solution of STS. Pharmaceutical grade sumatriptan
succinate sample (purity 99.5%) was received from MSN
laboratories, Hyderabad, India, as gift sample andwas used as
received. A stock standard solution equivalent to 1.0mgmL−1
of STS was prepared by dissolving accurately weighed 250mg
of pure drug in water and diluted to mark in a 250mL cali-
brated flask with the same solvent. The solution (1mgmL−1
STS) was used in titrimetric work and diluted appropriately
with water to get the working concentrations of 30 and
10 𝜇gmL−1 STS for use in spectrophotometric method B and
method C, respectively.
Two brands of tablets, namely, Suminat-25 and Suminat-
50 (Sun Pharmaceuticals Ltd., Sikkim, India), both were
purchased from local commercial sources.
2.3. General Procedures
2.3.1. Titrimetry (Method A). A 10.0mL aliquot of pure
drug solution containing 1.0–10.0mg of STS was measured
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Table 1: Comparison of the proposed and the existing visible spectrophotometric methods.
Sl. no. Reagent/s Methodology 𝜆max, nm
Beer’s law range
𝜇gmL−1
(𝜀 in Lmol−1 cm−1)
Remarks Reference
1
(a) Brucine-sodium
metaperiodate
Oxidative coupling
product was
measured
520 4.0–20.0NA Less sensitive, multistep reaction [28]
(b) Citric acid-acetic
anhydride 580
8.0–24.0
NA
2 Sodium nitroprussideacetaldehyde
Inner molecular
complex formed was
measured
552 4.0–20.0(1.10 × 104)
Less sensitive, requires rigid pH
control [29]
3 Cobalt thiocyanate
Extracted ternary
complex formed by
reaction with drug
was measured
629.4 16.0–48.0(3.97 × 103)
Less sensitive, involves extraction
step [30]
4 Tropaeolin-OOO
Extracted ion-pair
complex was
measured
482.5 2.0–10.0(2.08 × 104)
Requires rigid pH control; involves
liquid-liquid extraction; use of
organic solvents
[31]
5
(a) Chloranil in
1,4-dioxane CT-complex
measured
548 5.0–25.0(1.00 × 104) Less sensitive, involves heating step,time consuming
[32]
(b) Chloranil and
acetaldehyde 660
20.0–60.0
(3.19 × 104)
6 p-Chloranilic acid CT-complexmeasured 520
9.28 × 102
20–184 Less sensitive; use of organic solvents [33]
7 Folin reagent
Chromogen formed
by reaction with
drug was measured
455.6 16.0–48.0(3.85 × 103)
Less sensitive, strict pH control, time
consuming [34]
8 Folin-Ciocaltaeu reagent Reduced FC-reagentwas measured 760
2.0–6.0
NA Narrow linear range, less sensitive [35]
9
Bromate-bromide-
(a) Methyl orange Unreacted bromine
was measured
508 0.2–1.6(1.90 × 105) Narrow linear range, multistepreaction, time consuming [36]
(b) Indigo carmine 610 2.0–12.0(2.71 × 104)
10
NBS No rigorous control of experimental
conditions, no heating or extraction
step, no use of organic solvents or
toxic chemicals, and sensitive with
wide linear dynamic range
Proposed
methods(a) Potassium Iodide Tri-iodide ion
measured
Starch-iodine
complex measured
370 0.6–15.0
(𝜀 = 2.10 × 10
4
)
(b) Potassium
Iodide-starch 570
0.2–4.0
(𝜀 = 7.44 × 10
4
)
NBS: N-bromosuccinimide. NA: not available.
accurately and transferred into a 100mL Erlenmeyer flask.
The solution was acidified by adding 5mL of 2.0M HCl.
Then 10mL of 0.01M NBS was added by means of a pipette
and the flask was let stand for 15min at room temperature.
Lastly, 5mL of 5%KI was added, and after 5min the liberated
iodine was titrated against 0.02M sodium thiosulphate using
1mL of 1% starch as an indicator. A blank experiment was
simultaneously performed.
The amount of STS was computed from the following
formula:
Amount (mg) = (
𝐵 − 𝐴) ×𝑀𝑟 × 𝑆
𝑛
, (1)
where 𝐵 is mL of titrant in the absence of sample, 𝐴 is mL of
titrant in the presence of the sample,𝑀
𝑟
is relative molecular
mass of drug, 𝑆 is strength of NBS, and 𝑛 is number of moles
of titrant reacting with per mole of STS.
2.3.2. Spectrophotometric Method B (Based on the Measure-
ment of Tri-Iodide Ion). Varying aliquots (0.2–5.0mL) of
standard STS solution (30 𝜇gmL−1) were accurately trans-
ferred into a series of 10mL calibrated flasks and the total
volume was adjusted to 5.0mL with water. One mL of 2M
HCl was added to each flask followed by the addition of 1mL
NBS solution (200𝜇gmL−1 in NBS). The content was mixed
well and let stand for 15min with occasional shaking. Then,
1.0mL of 3M sodium acetate solution was added to each
flask followed by 1mL of 2% potassium iodide. The volume
was brought to the mark with water and the absorbance of
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Scheme 1: Proposed reaction pathway for the bromination of STS by NBS.
the resulting tri-iodide ion was measured at 370 nm after
5min against water blank.
2.3.3. Spectrophotometric Method C (Based on the Measure-
ment of Starch-Iodine Complex). Into a series of 10mL cali-
brated flasks, different aliquots (0.2–4.0mL) of standard STS
(10 𝜇gmL−1) solution were transferred using a microburette.
The total volume in each flask was brought to 4mL by
adding required quantity of water. The solution was acidified
by adding 1mL of 2M HCl, and 1mL of NBS (60 𝜇gmL−1
in NBS) solution was then added to each flask. The flasks
were kept aside for 15min with periodic shaking; 1mL of
2% potassium iodide was added and the content was mixed
well. After 5min, 1mL of 1% starch solution was added to
each flask and the volume was made up to the mark with
water and mixed well. The absorbance of the resulting blue
chromogen wasmeasured at 570 nm against water blank after
5min.
A standard graph was prepared by plotting absorbance
against concentration and the unknown concentration was
read from the graph or computed from the regression
equation derived using Beer’s law data.
2.3.4. Assay Procedure for Tablets. Twenty tablets each con-
taining 25 or 50mg of STS were weighed accurately and
ground into a fine powder. To prepare a standard stock solu-
tion of tablet, an amount of the powder equivalent to 100mg
of STSwas accurately weighed into a 100mL volumetric flask,
and 60mL water was added and content shaken thoroughly
for about 20min. The volume was diluted to the mark with
water, mixed well, and filtered using Whatman no. 42 filter
paper. First 10mL portion of the filtrate was rejected and a
convenient aliquot of filtrate (containing 1mgmL−1 STS) was
taken for assay by titrimetric procedure. Further, the standard
stock solution of tablet was diluted stepwise to achieve 30
and 10 𝜇gmL−1 of STS for use in spectrophotometric method
B and method C, respectively. A suitable aliquot was then
subjected to analysis following the procedures described
earlier.
2.3.5. Procedure for the Analysis of Placebo Blank and Synthetic
Mixture. A placebo blank containing starch (10mg), acacia
(15mg), hydroxyl cellulose (20mg), sodium citrate (30mg),
lactose (10mg), talc (60mg), acacia (30mg), magnesium
stearate (25mg), and sodium alginate (30mg) was prepared,
and 20mg of the placebo blank was extracted with water and
the solution was made as described under “assay procedure
for tablets” and then subjected to analysis.
A synthetic mixture was prepared by adding 50mg of
STS to about 25mg of the placebo blank prepared earlier,
homogenized, and the solution was prepared as done under
“assay procedure for tablets.” The filtrate was collected in
a 50mL flask. The synthetic mixture solution was analysed
by titrimetry and then appropriately diluted with water to
get 30.0 and 10.0 𝜇gmL−1 STS solutions, and appropriate
aliquots were subjected to analysis by method B and method
C, separately.
3. Results and Discussion
3.1. Chemistry. NBS is widely used as an oxidizing or bromi-
nating reagent for the determination of many pharmaceu-
tically important compounds [38–41]. It is also a specific
reagent for the bromination of organic compounds at allylic
position [42]. As NBS is a mild oxidizing agent, the only
possible reaction between STS and NBS would be bromi-
nation at the two allylic positions and a secondary amine
present in pyrrole ring present in STS.This was supported by
a reaction stoichiometry of 1 : 3 between STS and NBS. The
possible reaction scheme is presented in Scheme 1. The pro-
posed methods are indirect and involve the determination of
unreacted NBS after allowing the reaction between STS and
a measured amount of NBS go to completion. The amount
of iodine liberated, by the reaction of unreacted NBS with
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Figure 2: Absorption spectra: 6.0 𝜇gmL−1 STS, tri-iodate (method
B); 2.0 𝜇gmL−1 STS, starch-iodide complex (method C).
potassium iodide, was either measured directly at 370 nm or
reacted with starch, and resulting blue colored chromogen
of starch-iodine complex was measured at 570 nm whereas
iodometric back titration procedure was used in titrimetry.
3.2. Optimization of Reaction Conditions
3.2.1. Titrimetry. Direct titration of STS with NBS was not
feasible due to slow reaction. In the indirect procedure, a
known excess of NBS was allowed to react with STS in acid
medium and the unreacted NBS was subsequently deter-
mined iodometrically. At optimum acid concentration (5mL
of 2M HCl in a total volume of 25mL), the reaction goes to
completion within 15min. At lower acid concentration (less
than 3mL of 5MHCl) the reaction stoichiometrywas slightly
less and at higher acid concentration (up to 8mL of 5MHCl)
regular stoichiometry was observed. Under the optimized
reaction condition, there was found to be a definite reaction
stoichiometry of 1 : 3 between STS and NBS within the range
of 1.0–10.0mg STS. Contact time of 5 minute, was sufficient
for the complete liberation of iodine from the unreactedNBS.
3.2.2. Spectrophotometry. In spectrophotometric methods,
the amount of iodine liberated, by the reaction of unreacted
bromine with potassium iodide, was either measured directly
at 370 in method B or reacted with starch, and resulting blue
colored chromogen of starch-iodide complex is measured at
570 nm for method C (Figure 2).
Optimization of NBS. To fix the optimum concentration
of NBS, different concentrations of NBS were treated with
a fixed concentration (1mL 2% KI) of potassium iodide
in method B and potassium iodide and starch (1mL 1%
starch) in method C in HCl medium and the absorbance
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Figure 3: Effect acid concentration on 12𝜇gmL−1 STS (method B)
and 3𝜇gmL−1 STS (method C).
wasmeasured at 370 nm and 570 nm, respectively. A constant
and maximum absorbance resulted in 20𝜇gmL−1 NBS in
method B and 6 𝜇gmL−1 NBS in method C. Hence, different
concentrations of STS were treated with 1mL of 200𝜇gmL−1
NBS (method B) and 60𝜇gmL−1 NBS (method C) in HCl
mediumbefore determining the residual NBS as illustrated in
the reaction Scheme 1.This facilitated the optimization of the
linear dynamic ranges over which procedure could be applied
for the assay of STS.
Effect of Acid Concentration. The reaction between STS and
NBS was performed in different acid media. Better results
were obtained in hydrochloric acid medium. The effect of
acid concentration on the reaction between STS and NBS
was studied by varying the concentration of HCl keeping
the concentrations of NBS and drug fixed. The reaction was
found to be rapid yielding a constant absorbance with max-
imum sensitivity and stability when the HCl concentration
wasmaintained in the range of 0.18–0.75M (0.5 to 3.0mL 2M
HCl). Therefore, 1mL of 2M HCl in a total volume of 6mL
(0.33M) was used in both methods (Figure 3).
Reaction Time and Color Stability. The effect of time on
the reaction between STS and NBS in the presence of
HCl was studied by keeping all other reaction conditions
unchanged. The absorbance of the colored species was mea-
sured after different reaction times (5.0–30.0min) and the
results showed that the reaction was complete within 15min
in both method B and C.The absorbance of yellow tri-iodide
ion in method B and starch-iodide complex chromogen in
method C remained stable for at least 1 hr.
Role of Sodium Acetate. The liberation of iodine in method
B did not stop even after 30min under the specified acidic
6 International Journal of Analytical Chemistry
Table 2: Regression and analytical parameters.
Parameter Method B Method C
𝜆max, nm 370 570
Beer’s law limits, 𝜇gmL−1 0.0–15.0 0.0–4.0
Molar absorptivity (𝜀), Lmol−1 cm−1 2.10 × 104 7.44 × 104
Sandell sensitivitya, 𝜇g cm−2 0.0197 0.0056
Limit of detection (LOD), 𝜇gmL−1 0.34 0.07
Limit of quantification (LOQ), 𝜇gmL−1 1.02 0.20
Regression equation, 𝑌b
Intercept (𝑎) 0.79 0.80
Slope (𝑏) −0.049 −0.19
Correlation coefficient (𝑟) 0.9996 0.9997
Standard deviation of intercept (𝑆
𝑎
) 0.074 0.078
Standard deviation of slope (𝑆
𝑏
) 0.009 0.037
aLimit of determination as the weight in 𝜇g per mL of solution, which corresponds to an absorbance of 𝐴 = 0.001 measured in a cuvette of cross-sectional
area 1 cm2 and 𝑙 = 1 cm.
b
𝑌 = 𝑎 + 𝑏𝑋, where 𝑌 is the absorbance,𝑋 is concentration in 𝜇gmL−1, 𝑎 is intercept, and 𝑏 is slope.
Table 3: Evaluation of intra-day and inter-day precision and accuracy.
Method STS∗ taken
Intra-day (𝑛 = 5) Inter-day (𝑛 = 5)
STS founda %RSDb %REc STS founda %RSDb %REc
A
(Titrimetry)
4.00 3.98 0.90 0.55 3.95 1.39 1.21
6.00 5.99 0.92 0.23 6.04 1.09 0.65
8.00 8.05 0.73 0.59 8.06 1.06 0.76
B
(Spectrophotometry)
6.00 6.06 0.97 0.96 6.08 1.83 1.42
9.00 9.10 1.04 1.06 9.12 1.57 1.32
12.0 11.9 1.02 0.94 11.9 1.40 1.12
C
(Spectrophotometry)
1.00 1.02 1.44 1.55 1.02 2.20 1.93
2.00 1.98 0.94 1.14 1.97 1.37 1.40
3.00 2.97 0.63 0.85 2.97 0.91 1.02
∗In method A, STS taken/found are in mg and they are 𝜇gmL−1 in methods B and C.
aMean value of five determinations.
bRelative standard deviation (%).
cRelative error (%).
conditions, but on adding sodium acetate the reaction ceased
immediately. The amount of sodium acetate required was
optimized as 1mL of 3M sodium acetate in a total volume
of 10mL. In method C, the reaction was ceased by optimum
amount of starch (1mL of 1% starch).
3.3. Method Validation. The proposed methods have been
validated for linearity, sensitivity, selectivity, precision, accu-
racy, and recovery according ICH guidelines [43].
3.3.1. Linearity, Detection, and Quantification Limits. The
reaction stoichiometry for the titrimetric procedure was 1 : 3
owing to the presence of two allylic groups and a secondary
aromatic amine in STS and the range of quantification was
1.0–10.0mg STS. A linear correlation was found between
absorbance and concentration of STS in the spectropho-
tometric methods. Regression analysis of Beer’s law data
using the method of least squares was made to evaluate the
slope (𝑏), intercept (𝑎), and the correlation coefficient (𝑟)
and the calculated values are given in Table 2. The graph
showed negligible intercept and is described by the regression
equation 𝑦 = 𝑎+𝑏𝑥, where 𝑦 is the measured absorbance and
𝑥 concentration in 𝜇gmL−1. The limits of detection (LOD)
and quantification (LOQ), sensitivity parameters such as
molar absorptivity, and Sandell sensitivity are also contained
in Table 2.
3.3.2. Accuracy and Precision. The accuracy of an analytical
method expresses the closeness between the reference value
and the found value. Accuracy was evaluated as percentage
relative error between the measured concentrations and
taken concentrations for STS (Bias%). The results obtained
are compiled in Table 3 and show that the accuracy is good
for the methods.
The precision of the method was calculated in terms
of intermediate precision (intra-day and inter-day). Three
different concentrations of STS were analyzed in seven
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Table 5: Results of analysis of tablets by the proposed methods.
Tablet brand name Label claim
mg/tablet
Found (percent of label claim ± SD)a
Reference method Proposed methods
Method A Method B Method C
Suminat-25 25 101.1 ± 0.83
99.52 ± 1.19 101.6 ± 1.45 101.8 ± 1.20
𝑡 = 2.44 𝑡 = 0.67 𝑡 = 1.07
𝐹 = 2.06 𝐹 = 3.05 𝐹 = 2.09
Suminat-50 50 99.43 ± 1.05
100.9 ± 0.81 101.2 ± 1.77 99.09 ± 1.83
𝑡 = 2.48 𝑡 = 1.92 𝑡 = 0.36
𝐹 = 0.60 𝐹 = 2.84 𝐹 = 3.04
aMean value of five determinations.
Tabulated 𝑡-value at the 95% confidence level is 2.78.
Tabulated 𝐹-value at the 95% confidence level is 6.39.
replicates during the same day (intra-day precision) and five
consecutive days (inter-day precision).TheRSD (%) values of
intra-day and inter-day studies showed that the precision was
good (Table 3).
3.3.3. Robustness and Ruggedness. To evaluate the robustness
of the methods, volume of HCl was slightly altered (5±1mL)
with reference to optimum values in titrimetry. However,
in spectrophotometry, the reaction time (after adding NBS,
time varied was 15 ± 1min in both methods B and C) and
volume of 2M HCl were slightly altered (1 ± 0.1mL) in both
B and C methods. To check the ruggedness, analysis was
performed using four different burettes in method A and
three different cuvettes in methods B and C. The robustness
and the ruggednesswere checked at three different drug levels
(4, 6, 8mg in method A; 6, 9, 12 𝜇gmL−1 in method B; and
1, 2, 3 𝜇gmL−1 in method C). The intermediate precision,
expressed as percent RSD, which is a measure of robustness
and ruggedness, was within the acceptable limits (0.89–
2.27%) as shown in Table 4.
3.3.4. Selectivity. The proposed methods were tested for
selectivity by placebo blank and synthetic mixture analyses.
A convenient aliquot of the placebo blank solution, prepared
as described earlier, was subjected to analysis by titrimetry
and spectrophotometry according to the general procedures.
In all the cases, there was no interference by the inactive
ingredients present in the placebo mixture.
A separate experiment was performed with the synthetic
mixture. The analysis of synthetic mixture solution prepared
earlier yielded percent recoveries which ranged from 98.77
to 102.6 with standard deviation of 0.89–1.74 in all the cases.
The results of this study indicate that the inactive ingredients
present in the synthetic mixture did not interfere in the assay.
These results further demonstrate the accuracy, as well as the
precision, of the proposed methods.
3.3.5. Application to Tablets Analysis. The proposed methods
were applied to determine STS in same brand of tablets
with two different doses.The results were statically compared
with those obtained by the published reference method [12]
for accuracy and precision by applying the Student’s t-test
and variance ratio F-test. The published reference method
describes UV-spectrophotometric method for detection of
STS in tablet formulation at 220 nm. Statistical analysis of
the results using Student’s t-test for accuracy and F-test
for precision revealed no significant difference between the
proposed methods and the reference method at the 95%
confidence level with respect to accuracy and precision
(Table 5).
3.3.6. Recovery Studies. The accuracy and validity of the
proposed methods were further ascertained by performing
recovery studies. Preanalysed tablet powder was spiked with
pure STS at three concentration levels (50%, 100%, and 150%
of that in tablet powder) and the total was found by the
proposed methods. The added STS recovery percent values
ranged between 98.20% and 103.0%with a standard deviation
of 0.05–1.56. The results of this study given in Table 6 indi-
cated that the recovery was good, and that the coformulated
substances did not interfere in the determination.
4. Conclusions
Three simple, sensitive, and selective methods are described
for the determination of STS in tablets employing NBS as
the brominating reagent. Titrimetry is applicable over 1.0–
10.0mg range, and it is the first titrimetric method has
ever been reported for the assay of STS in pharmaceuticals.
The proposed spectrophotometricmethods are characterized
by high sensitivity and stability of the measured colored
species.The proposed spectrophotometric methods are more
sensitive than most of the reported methods in terms of
both linear range and molar absorptivity. The proposed
methods are simple, rapid, economic, and not involved in
strict pH control and use of organic solvents, whereas most
of the reported methods require rigid pH control, extraction
step, and multistep reactions. Besides, the methods possess
adequate accuracy and precision, and no interference from
International Journal of Analytical Chemistry 9
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the excipients and coating materials was found. Hence, the
methods can be employed for routine analysis in quality
control laboratories.
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